Abstract
Most West Nile virus (WNV) infections are asymptomatic, but some lead to neuroinvasive disease with symptoms ranging from disorientation to paralysis and death. Evidence from animal models suggests that neuroinvasive infections may arise as a consequence of impaired immune protection. However, other data suggest that neurologic symptoms may arise as a consequence of immune mediated damage. We demonstrate that elevated immune responses are present in neuroinvasive disease by directly characterizing WNV-specific T cells in subjects with laboratory documented infections using human histocompatibility leukocyte antigen (HLA) class II tetramers. Subjects with neuroinvasive infections had higher overall numbers of WNV-specific T cells than those with asymptomatic infections. Independent of this, we also observed age related increases in WNV-specific T cell responses. Further analysis revealed that WNV-specific T cell responses included a population of atypically polarized CXCR3+CCR4+CCR6- T cells, whose presence was highly correlated with neuroinvasive disease. Moreover, a higher proportion of WNV-specific T cells in these subjects co-produced interferon-γ and interleukin 4 than those from asymptomatic subjects. More globally, subjects with neuroinvasive infections had reduced numbers of CD4+FoxP3+ Tregs that were CTLA4 positive and exhibited a distinct upregulated transcript profile that was absent in subjects with asymptomatic infections. Thus, subjects with neuroinvasive WNV infections exhibited elevated, dysregulated, and atypically polarized responses, suggesting that immune mediated damage may indeed contribute to pathogenic outcomes.
Highlights
Since its emergence in 1999, West Nile virus (WNV) has become a leading cause of encephalitis in North America
Most West Nile virus (WNV) infections are asymptomatic, but some lead to neuroinvasive disease with symptoms ranging from disorientation to paralysis and death
We demonstrate that subjects with neuroinvasive West Nile Virus infections have exaggerated and atypical responses to the virus
Summary
Since its emergence in 1999, West Nile virus (WNV) has become a leading cause of encephalitis in North America. Seasonal outbreaks in various states have led to thousands of documented cases of WNV infection and perhaps millions of undocumented cases, based on serological estimates [1]. Epidemiological data indicate that the majority of WNV infections are essentially asymptomatic [2]. A minor yet significant percentage of infections lead to neuroinvasive disease [3]. The symptoms elicited by neuroinvasive WNV infection can include ocular manifestations, muscle weakness, cognitive impairment, tremors, flaccid paralysis, and death, making this virus a significant health concern [4]. While effective vaccines have been developed for other flaviviruses, including yellow fever and Japanese encephalitis, there is currently no approved human vaccine for WNV. A more comprehensive understanding of immune responses elicited by the virus, including the aspects of these responses that accompany favorable and unfavorable outcomes, is a highly desirable goal
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
